1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Platform
1.2.3 Service
1.3 Market by Application
1.3.1 Global Phenotypic Drug Discovery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Viral Infection
1.3.4 Genetic Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Phenotypic Drug Discovery Market Perspective (2017-2028)
2.2 Phenotypic Drug Discovery Growth Trends by Region
2.2.1 Phenotypic Drug Discovery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Phenotypic Drug Discovery Historic Market Size by Region (2017-2022)
2.2.3 Phenotypic Drug Discovery Forecasted Market Size by Region (2023-2028)
2.3 Phenotypic Drug Discovery Market Dynamics
2.3.1 Phenotypic Drug Discovery Industry Trends
2.3.2 Phenotypic Drug Discovery Market Drivers
2.3.3 Phenotypic Drug Discovery Market Challenges
2.3.4 Phenotypic Drug Discovery Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Phenotypic Drug Discovery Players by Revenue
3.1.1 Global Top Phenotypic Drug Discovery Players by Revenue (2017-2022)
3.1.2 Global Phenotypic Drug Discovery Revenue Market Share by Players (2017-2022)
3.2 Global Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phenotypic Drug Discovery Revenue
3.4 Global Phenotypic Drug Discovery Market Concentration Ratio
3.4.1 Global Phenotypic Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phenotypic Drug Discovery Revenue in 2021
3.5 Phenotypic Drug Discovery Key Players Head office and Area Served
3.6 Key Players Phenotypic Drug Discovery Product Solution and Service
3.7 Date of Enter into Phenotypic Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Phenotypic Drug Discovery Breakdown Data by Type
4.1 Global Phenotypic Drug Discovery Historic Market Size by Type (2017-2022)
4.2 Global Phenotypic Drug Discovery Forecasted Market Size by Type (2023-2028) 5 Phenotypic Drug Discovery Breakdown Data by Application
5.1 Global Phenotypic Drug Discovery Historic Market Size by Application (2017-2022)
5.2 Global Phenotypic Drug Discovery Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Phenotypic Drug Discovery Market Size (2017-2028)
6.2 North America Phenotypic Drug Discovery Market Size by Country (2017-2022)
6.3 North America Phenotypic Drug Discovery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Phenotypic Drug Discovery Market Size (2017-2028)
7.2 Europe Phenotypic Drug Discovery Market Size by Country (2017-2022)
7.3 Europe Phenotypic Drug Discovery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Phenotypic Drug Discovery Market Size (2017-2028)
8.2 Asia-Pacific Phenotypic Drug Discovery Market Size by Country (2017-2022)
8.3 Asia-Pacific Phenotypic Drug Discovery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Phenotypic Drug Discovery Market Size (2017-2028)
9.2 Latin America Phenotypic Drug Discovery Market Size by Country (2017-2022)
9.3 Latin America Phenotypic Drug Discovery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Phenotypic Drug Discovery Market Size (2017-2028)
10.2 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2017-2022)
10.3 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Detail
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery Phenotypic Drug Discovery Introduction
11.1.4 Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.1.5 Eurofins Discovery Recent Development
11.2 Sygnature Discovery
11.2.1 Sygnature Discovery Company Detail
11.2.2 Sygnature Discovery Business Overview
11.2.3 Sygnature Discovery Phenotypic Drug Discovery Introduction
11.2.4 Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.2.5 Sygnature Discovery Recent Development
11.3 PsychoGenics
11.3.1 PsychoGenics Company Detail
11.3.2 PsychoGenics Business Overview
11.3.3 PsychoGenics Phenotypic Drug Discovery Introduction
11.3.4 PsychoGenics Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.3.5 PsychoGenics Recent Development
11.4 siTOOLs Biotech
11.4.1 siTOOLs Biotech Company Detail
11.4.2 siTOOLs Biotech Business Overview
11.4.3 siTOOLs Biotech Phenotypic Drug Discovery Introduction
11.4.4 siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.4.5 siTOOLs Biotech Recent Development
11.5 PhoreMost
11.5.1 PhoreMost Company Detail
11.5.2 PhoreMost Business Overview
11.5.3 PhoreMost Phenotypic Drug Discovery Introduction
11.5.4 PhoreMost Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.5.5 PhoreMost Recent Development
11.6 Charles River
11.6.1 Charles River Company Detail
11.6.2 Charles River Business Overview
11.6.3 Charles River Phenotypic Drug Discovery Introduction
11.6.4 Charles River Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.6.5 Charles River Recent Development
11.7 MaxWell
11.7.1 MaxWell Company Detail
11.7.2 MaxWell Business Overview
11.7.3 MaxWell Phenotypic Drug Discovery Introduction
11.7.4 MaxWell Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.7.5 MaxWell Recent Development
11.8 Arctoris
11.8.1 Arctoris Company Detail
11.8.2 Arctoris Business Overview
11.8.3 Arctoris Phenotypic Drug Discovery Introduction
11.8.4 Arctoris Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.8.5 Arctoris Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
